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The dendritic cell has been  shown to be extremely effective at activating T 
lymphocytes involved in allogeneic, mitogenic, or TNP-specific responses (1-6). 
Previous studies (7, 8) have also suggested that the dendritic cell can participate 
in the presentation of soluble antigens to suitably primed T  cells. These studies 
did not definitively indicate,  however,  whether  the  dendritic cells  themselves 
were  able  to present  soluble antigens to  syngeneic T  cells  nor whether  these 
effects  could  be  seen  in  the  absence  of any  other  potential  contaminating 
accessory cell in the indicator T  cell population. We have now addressed these 
issues by using T  cell hybridomas that proliferate autonomously in culture. When 
triggered by antigen in the presence of spleen cells of the appropriate haplotype, 
the hybridomas release interleukin 2  (IL-2) (9-11).  Our studies were designed 
to test the idea that nominal antigen plus purified dendritic cells activate antigen- 
specific hybridomas to produce IL-2 in a  genetically restricted fashion. 
Materials and Methods 
Mice.  (CBA/N X BALB/c)F~ male mice were the generous gift of Dr. Brigitte Huber, 
Tufts University Medical School. DBA/2 males were obtained from The Jackson Labo- 
ratory, Bar Harbor, ME and maintained in the Tufts University Medical School Animal 
Colony, as were CBA/Tufts mice. 
Antigens.  Ovalbumin (OVA) was obtained from the Sigma Chemical Co., St.  Louis, 
MO; keyhole limpet hemocyanin (KLH) was the generous gift of Dr. Marvin Rittenberg, 
University of Oregon Health Science Center, Portland, OR. 
Preparation of Spleen Dendritic Cell and Macrophage Fractions.  Dendritic cells and spleen 
macrophages were obtained as previously described (2, 7). Briefly, spleen cells were spun 
on  a  discontinuous bovine  serum  albumin  (Path-O-Cyte 4;  Miles  Laboratories,  Inc., 
Kankakee, IL) gradient of densities 10, 23, 26, 29, and 35% for 30 rain at 18,000 g. The 
interface of 10-23% was removed and cultured for 2 h in RPMI plus 5% fetal calf serum 
(fetal bovine serum; Dutchland Laboratories, Inc., Denver, PA) containing 5 X 10  -5 M 
mercaptoethanol, 10 mM Hepes, and 2 mM L-glutamjne (complete medium). Nonadher- 
ent (NAd) cells were discarded and the medium was replaced. After a further 18 h in 
culture, 90% of the cells were nonadherent. NAd cells were then separated by Fc receptor 
(FcR) rosetting, using rabbit anti-sheep cell antibody (7S IgG fraction; Cordis Laboratories, 
Inc., Miami, FL)-coated sheep erythrocytes (EA) at 37°C as previously described (2,  7). 
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Since phagocytosis of EA may decrease macrophage viability (12), in some experiments 
EA  rosetting was  also  performed at  4°C.  FcR  + and  FcR-  (dendritic) cells  were then 
separated over Ficoll-Hypaque and bound EA were removed by hypotonic shock. The 
characteristics  of the  cells  prepared  by  this  method  have  been  extensively analyzed 
previously (2, 7). The FcR- cells were nonphagocytic and were 80-90% I-A  +. The FcR  ÷ 
fraction was phagocytic (>90% ingesting latex) and stained with nonspecific esterase; 50- 
60% of the cells were I-A  +. Where indicated, FcR- cells were rerosetted with fresh EA 
for a further 45 min and respun on FicolI-Hypaque. Recoveries of 70-80% were obtained 
in the twice-treated interface. 
T Cell Hybridomas.  The T  cell hybridomas D011.10,  AODH-3.4, and AODK-10.4, 
which secrete IL-2 when stimulated with OVA plus I-A  d, OVA plus I-A  k, and KLH plus 
I-A  d, respectively (9, 11), were used in these studies. 
Anti-IA Reagents.  Cells producing monoclonal anti-I-A  k 10.2.16 were kindly provided 
by the laboratory of Dr. L. A. Herzenberg via the Salk Institute Cell Distribution Center, 
LaJolla, CA. Cells producing monoclonal anti-I-A  d MK-D6 have been previously described 
(9). Culture supernatant from exhausted cell cultures was used as the source of antibody 
at a final concentration of 1  : 10 in our assays. 
Induction oflL-2.  5-10 X  10 4 T  cell hybridomas were incubated in complete medium 
in duplicate in round-bottomed 96-well culture trays (Linbro 76-013-05; Flow Laborato- 
ries, Inc., McLean, VA) with graded numbers of accessory cells irradiated with 2,000 rad. 
Medium, 1 #g concanavalin A or 200 ~g antigen, v.as added to each well to make a total 
volume of 200 #1. After 24 h at 37°C, 165 ~1 of supernatant (SN) was removed from each 
well and duplicate SN pooled. In some experiments, these SN were frozen at -20°C until 
the assay. 
Assay for IL-2.  An IL-2-addicted line, CTLL, originally derived by Gillis and Smith 
(13),  was obtained from Dr. Paula Hochman, Tufts University Medical School. 8-10 x 
103 CTLL cells  were incubated with  100 or 50 #1 SN in triplicate in round-bottomed 
wells for 24 h as described above.  1 uCi [SH]thymidine ([3H]TdR) was included for the 
final 6 h. [3H]TdR counts were directly proportional to the number of hybridoma cells in 
the initial  incubation as well as the volume of supernatant included in the CTLL assay 
(data not shown). 
Results 
Induction oflL-2 by Dendritic Cells.  The T  cell hybridoma DO 11.10 has previ- 
ously  been  shown  (11)  to  produce  IL-2  only  when  cultured  with  OVA  in 
association with products of I-A  d. Table I indicates that if DO 11.10 is incubated 
with 1 ×  106 DBA/2 spleen cells, high levels of IL-2 are produced in the presence 
but not the absence of OVA. Low numbers of unfractionated spleen cells induced 
little IL-2. Equally low numbers of DBA/2 dendritic cells (1-2 ×  104), however, 
induced  very  high  levels  of  IL-2  production:  2  ×  10  4  dendritic  cells  were 
equivalent  in  effect to  1  ×  10 6  unfractionated  spleen  cells.  Interestingly,  the 
FcR  + fraction isolated under the same conditions as the dendritic cell population 
(by EA rosetting at 37 °) had only a  slight effect on IL-2 production at either  1 
or  2  ×  10 4  cells  per  well  when  co-cultured  with  antigen.  The  levels of IL-2 
produced approximated  those induced by the same  number of unfractionated 
spleen cells. Table I also indicates that induction of hybridoma IL-2 production 
by dendritic  cells  is  genetically restricted  since  2  ×  10 4  CBA  (H-2  k)  dendritic 
cells were totally ineffective in activating the hybridoma. 
Presentation  of KLH by Dendritic Cells.  We also tested  to see  if a  hybridoma 
specific  for a  much  larger  soluble  antigen,  KLH,  could  recognize antigen  in 
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TABLE  I 
Dendritic  Cells Induce IL-2 Production  by an Ovalbumin-specific T Cell Hybridoma,  D011.10, in 
a Genetically Restricted Fashion 
Accessory cell present during 
incubation with D011.10 
[SH]TdR incorporation 
No antigen  OVA 
None 
DBA/2 1 X  108 spleen cells 
DBA/2 1 x  104 spleen cells 
DBA/2 2 X  l04 NAd FcR- (dendritic cells) 
DBA/2 1 x  104 NAd FcR-(dendritic cells) 
DBA/2 2 x  104 NAd FcR÷ 
DBA/2 1 ×  104 NAd FcR÷ 
CBA 2 x  104 NAd FcR- 
cpm ± SD 
1,296 ±  126  1,132 ±  17 
1,041 ±  148  20,196 ±  3,580 
1,549 +  78  2,546 ±  40 
1,102 ±  126  16,040 ±  2,981 
1,935 ±  782  9,017 ±  178 
1,110 ±  308  2,700± 322 
1,220 ±  164  1,987 ±  290 
1,135 ±  52  1,370 ±  122 
Irradiated accessory cells were incubated for 24 h  with l0  s D011.10 cells in the presence or absence of 200 #g 
OVA. Supernatants were removed and 100 #1 tested for IL-2 activity on 104 CTLL cells. 1 #Ci [3H]TdR was added 
for the last 6 h of a 24 h incubation. CTLL cells +  medium: 1,356 ±  192; CTLL cells +  21/~% T  cell growth factor: 
15,018 ±  772. Results shown are representative of three experiments. 
TABLE II 
Dendritic Cells Induce IL-2 Secretion by a KLH-spec~c Hybridoma AODK-IO. 4 
DBA/2 accessory cell present  [SH]TdR incorporation 
Exp.  during incubation with 
AODK- 10.4  No antigen  KLH 
cpm ± SD 
1 ×  106 spleen  382 ±  127  6,927 ±  1,612 
1 ×  104 spleen  248 +  163  190 ±  56 
2  x  104 NAd FcR-  177 ±  98  6,184 ±  1,965 
1 ×  104 NAd FcR-  341 3= 97  5,667 ±  956 
None  825 ±  46  1,029 ±  122 
1 x  104 spleen  689 ±  33  1,057 ±  5 
2 x  104 NAd FcR-*  1,250 ±  131  7,936 ±  1,975 
1  X  104 NAd FcR-  565 ±  283  7,300 ±  846 
0.5 ×  104 NAd FcR-  720 ±  251  5,805 ±  973 
2 ×  104 NAd FcR  +*  1,186 ±  106  6,220 ±  656 
1 ×  104 NAd FcR +  899 ±  355  2,087 ±  885 
0.5 ×  104 NAd FcR  +  1,131 +  567  1,255 ±  376 
Experimental conditions as in legend to Table 1 except 4  ×  104 hybridoma cells were used and 50~ supernatant 
tested on 8  ×  l0  s CTLL cells. Experiment 1, CTLL alone: 173 ±  26; CTLL +  2.5% cell growth factor (TCGF): 
22,024 ±  2,362; experiment 2, CTLL alone: 235 ±  85; CTLL +  2.5% TCGF:  18,215 +  1,054. Results for each 
experiment are representative of at least three repetitions. 
*FcR- population rerosetted with a further round of EA for 45 min at 4°C. 
* FcR  + population derived by EA rosetting for 45 rain at 4°C. 
10  4 dendritic cells induced high levels of IL-2 in the presence of KLH; in several 
experiments these levels were as high or higher than those generated by 1 ×  10  6 
unfractionated spleen  cells.  In  the  second  part  of Table  II,  FcR-  and  FcR  + 
fractions were compared for their ability to induce hybridoma IL-2 secretion in 
the presence of antigen. To avoid potential problems of EA phagocytosis leading 
to decreased viability (12), EA rosetting was performed at 4°C. The FcR- fraction 
was  also subjected to a  further round of EA  rosetting at 4°C  to remove any 
residual FcR  ÷ cells.  The resultant FcR- population was still  highly effective at 
inducing IL-2 secretion in the presence of KLH over the range 0.5-2 ×  104  (in 
some experiments as few as  1 ×  l0 s cells  were effective). In a series of experi- 
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TABLE III 
Monoclonal Anti-LA Specifically Blocks Dendritic Cell-induced Hybridoma IL-2 Production 
Accessory cell present 
during incubation with 
hybridoma 
[SH]TdR incorporation 
Hybridoma tested 
AODH-3.4  D011.10 
No antigen  OVA  No antigen  OVA 
None 
2 ×  104 (CBA/N ×  BALB/c)F~ 
NAd FcR- cells* 
Plus anti-I-A  k 
Plus anti-I-A  d 
1 #g concanavalin A alone 
cpm 3= SD 
521 3= 113  532 3= 94  361 3= 60  333 3= 40 
1,436 3= 177  4,420 3= 274  737 3= 202  1,765 3= 316 
1,747 3= 192  1,564 3= 922  339 5- 57  2,649:1:204 
649 3= 136  4,908 3= 5  410 3= 39  532 3= 36 
9,794 3= 628  3,578 3= 701 
Experimental conditions as  in  legend for  Table  I  except that  6  x  104  hybridoma cells  were used and  50 ul 
supernatant was tested for IL-2 activity at 24 h. CTLL cells +  medium: 391  3=  190; CTLL cells +  2.5% T  cell 
growth factor: 14,421:1=  903. Results are representative of three experiments. 
* Dendritic cells rerosetted for 45 rain with fresh EA, 
levels but titrated out rapidly over the dose range at which dendritic cells were 
active. 
Monoclonal Antid-A Sera  Block Dendritic Cell Induction  of lL-2.  To test for the 
site of the genetic restriction in the interaction of dendritic cells and T  cells, we 
assayed two hybridomas,  D011.10  and AODH-3.4,  which respond  to OVA in 
association with Iad and Ia  k products, respectively. (CBA/N × BALB/c)F~ spleen 
cells, which express both I-A  k and LA  d determinants,  were used as the source of 
dendritic cells for these experiments. Table III shows that in the presence of Fa 
dendritic cells (prepared by rerosetting the FcR- with fresh EA) and ovalbumin, 
significant levels of IL-2 were induced in both hybridomas. (It should be stressed 
that IL-2 values in this table are -~25% those found in Table I. This is because 
both supernatant volume and hybridoma number were reduced by 50%.) If anti- 
I-A  d was also added,  however, dendritic  cell presentation  of OVA to DO 11.10 
was completely inhibited,  whereas anti-I-A k had  no effect on IL-2 production. 
This pattern of anti-I-A blocking was reversed for OVA presentation to AODH- 
3.4, demonstrating not only the importance of I-A on the dendritic cell but also 
the specificity of the hybridoma for the relevant I-A plus antigen moiety. 
Discussion 
One of the major problems in asking which cells are able to present antigen to 
T  cells has been the difficulty in totally depleting the indicator T  cell population 
of endogenous  accessory cells.  This  difficulty has  been  circumvented  by the 
recent use of antigen-specific T  cell hybridomas that are self-replicating in the 
absence of any "filler" cell (9-11) and which, when triggered by either concana- 
valin A  or antigen  plus spleen cells of the appropriate  haplotype, produce the 
soluble mediator IL-2. The production of this mediator in this system has been 
used in several laboratories as an index of antigen presentation (9-11,  14-16). 
We have found that in the presence of soluble antigen, low numbers of splenic 
dendritic  cells  can  induce  IL-2  production  by  hybridomas.  This  response  is 
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ceil, since appropriate antM-A sera block IL-2 induction. Alternative explana- 
tions for our findings have also been considered. One possibility is that a small 
contaminating population  of macrophages within the dendritic cell fraction is 
responsible for all the effects described here. We feel this is unlikely since, as 
described above, the FcR  + population isolated at the same density as dendritic 
cells is not as effective at presenting antigen as dendritic cells over the effective 
titration range. Furthermore, in two sets of experiments, the FcR- fraction was 
rerosetted with EA and the remaining FcR- cells still  presented antigen to the 
hybridoma  (Tables  II  and  III).  Indeed,  this  FcR-  population  also  induced 
hybridoma IL-2 secretion when preincubated rather than co-cultured with high 
concentrations of ovalbumin or KLH (data not shown). We therefore feel that 
the  simplest  explanation  for  our  data  is  that  dendritic  cells  are  presenting 
exogenous soluble antigens in association with surface I-A products to T  cells. 
The low density macrophage population that we have isolated is less effective 
at presenting soluble antigens than the dendritic cell fraction and it is possible 
that this lower level of activity may be contributed by contaminating dendritic 
cells. Why the NAd FcR  ÷ fraction used in these and previous studies is not as 
effective at presenting protein antigens is unclear. It contains a high proportion 
of I-A  + cells (7),  and other I-A  + cells such as macrophage tumors and B  cell 
lymphomas have  been  shown  to  present antigen  to  the hybridomas (14-16). 
There may, however, be subtle biochemical differences between the Ia deter- 
minants of these populations, as has been documented for B cell versus macro- 
phage I-A (17), and this may be functionally relevant. It is unlikely that the FcR  ÷ 
cells  are  actively  suppressing  the  antigen-specific response  since  preliminary 
experiments indicate that  mixing the FcR  ÷ and  FcR- populations even at  1:1 
ratios  does  not  inhibit  the  dendritic  ceil-induced response.  Experiments  are 
underway to clarify these issues. 
The fact that dendritic cells do not phagocytose, have few lysosomes, and are 
poorly pinocytic (18) leaves open the question of how these cells present poly- 
peptide  antigens  to  T  cells.  Since cells with  similar characteristics have  been 
described in vivo (19),  we suggest that these cells may play a  key physiological 
role in the activation of syngeneic antigen-specific T  cells. 
Summary 
In the presence of the soluble polypeptide antigens ovalbumin and keyhole 
limpet hemocyanin, purified mouse spleen dendritic cells induce the secretion of 
IL-2 by antigen-specific T  cell hybridomas. This response is H-2 restricted and 
can be specifically inhibited by monoclonal anti-I-A.  These data indicate that 
dendritic cells can present soluble antigen to H-2-compatible T  cells. 
We thank Ophelia Gabriel and Andrea Simonsen for their help with these studies. 
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